[10] [11] The mechanism by which these medications reduce appetite involves both peripheral and central pathways
After randomization, participants completed monthly mid-study visits at 1-month (Month 1), 2-month (Month 2), and the end of study visit at 3 months (Month 3) for the final measurement of outcomes of interest, including the final MR scan
Lancet 397 , 971984 (2021)
Bae M, Cassilly CD, Liu X, et al
Apoptosis and glutathione: Beyond an antioxidant Wu G., et al
TRIUMPH-4: Osteoarthritis pain signal Because TRIUMPH-4 specifically enrolled participants with symptomatic knee osteoarthritis, it also collected WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index) pain data